IND-enabling services
The Food and Drug Administration’s Investigational New Drug( IND) program is the method that which a pharmaceutical company is granted permission to transport an experimental drug over states (usually to clinical researchers) before the time a marketing request for the drug is approved. The FDA evaluates the IND-enabling services. For safety to ensure that research subjects are not placed at risk in any way. When the application has been approved the drug candidate typically is placed in an initial clinical trial.
